Authors
Loading...
Persistent uncertainty on anticoagulants in occlusive disease; leaves open optimal management pending definitive trials.
Key points are not available for this paper at this time.
P. A. Owren (1963) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: